| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |